Project Grant R01DK140187
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $158,943 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to New York University (NYU) to pilot a community-engaged intervention to support South Asian patients with type 2 diabetes who are at risk for depression. The 5-year project will adapt NYU's existing DREAM diabetes self-management program to incorporate mental health and digital health...
- This federal Project Grant award in the amount of $711,791 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of the grant is to conduct a large longitudinal cohort study to better understand the epidemiology of type 2 diabetes among Asian American, Native Hawaiian, and Pacific Islander adolescents and young adults in the Kaiser Permanente Northern...
- This $147,459 federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), supports research to address racial and ethnic disparities in diabetes risk after varying glycemia levels during pregnancy. The research will focus on understanding whether future diabetes risk after gestational diabetes mellitus (GDM) and gestational glucose intolerance (GGI) differs across...
- This federal Project Grant award of $319,990 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a 12-week randomized controlled trial to compare medical nutrition therapy personalized by continuous glucose monitoring (CGM) feedback to three control interventions in 72 adult participants with type 2 diabetes mellitus. The primary objective is to determine if CGM-informed personalized...
- This Project Grant award of $819,091 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to identify high-risk subgroups and glucose patterns associated with disease progression and clinical outcomes in persons with and without diabetes. The Johns Hopkins University, a leading private research university, will conduct this work using continuous glucose monitoring (CGM) systems and...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is providing $165,541.00 to Scripps Health to integrate continuous glucose monitoring (CGM) devices into their Project DULCE diabetes education curriculum for Latino adults with type 2 diabetes. The goal is to understand barriers and facilitators to CGM adoption, develop implementation strategies,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant of $769,155 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Michigan. The grant, titled "Michigan Diabetes Project: A Self-Management Intervention to Improve Type 2 Diabetes Outcomes in Adults", aims to conduct a two-arm, hybrid type 1 effectiveness-implementation trial comparing a tailored diabetes...
- This $731,071 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to address challenges that prevent the provision of guideline-recommended diabetes care in the United States. The project will leverage real-world datasets on 17.4 million people with diabetes to: Describe differences in care receipt by individual, neighborhood, and insurance characteristics (Aim 1);...
- This federal Project Grant award of $192,215 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to improve treatment persistence for patients with type 2 diabetes and chronic kidney disease through enhanced risk communication approaches. The key activities include rigorously developing an effective risk communication aid to translate individualized cardiovascular...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $843,485 project grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Duke University. The grant, running from September 2025 to August 2030, will assess the impact of two novel, population-tailored health insurance designs on diabetes outcomes for approximately 1.75 million working-age adults. The project aims to evaluate whether providing more generous...
The federal Project Grant award, titled "ADAPTIVE DIETARY INTERVENTION (ADI) LEVERAGING CONTINUOUS GLUCOSE MONITORING FOR ASIAN AMERICANS WITH TYPE 2 DIABETES", is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $970,016 award to New York University aims to evaluate the feasibility, acceptability, and effectiveness of an adaptive dietary intervention that integrates continuous glucose monitoring and culturally-tailored strategies to improve glycemic control for Asian Americans with Type 2 diabetes. This research project, spanning from September 2025 to August 2028, seeks to address the prominent disparities in diabetes care and management faced by the fast-growing Asian American population in the U.S.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $970.0k | 9/17/25 |